Common variants for atrial fibrillation: results from genome-wide association studies.

Abstract excerpt

Atrial fibrillation (AF) affects more than 5 million people worldwide; however, none of the anti-arrhythmic drugs available now are entirely optimal in terms of efficacy and safety. A better understanding of the molecular mechanism of AF will facilitate the process of finding new strategies to prevent AF. As the non-familial AF is the major form of AF, identifying common variants for AF in these populations by...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Atrial Fibrillation
• Share to Cardiac electrophysiology and arrhythmias